Ir. Peter Morel becomes the new CEO of Osimis,
Dr. Sergey Morozov joins soon as CIO,
after Cédric Constant successfully pivoted the company
Liège, April 28, 2022. The Board of Directors of Osimis has appointed ir. Peter Morel, MBA as new CEO. "After having raised €1.6 million in early February, we are welcoming Peter, with his strong experience in developing complex international collaboration models in a fast evolving market of IT solutions helping companies to adopt emerging digital technologies”. “We also want to warmly thank Cédric Constant who has led the strategic pivot of Osimis into a distributor and integrator of artificial intelligence solutions for radiology workflows.” says Jacques Galloy, Chairman of the Board of Directors of Osimis.
"I am delighted to join Osimis at the crossroads of an evolution in the radiology business. Having obtained international recognition for the quality delivered with the Orthanc platform, our goal is to become the market reference for introducing a multitude of artificial intelligence solutions into radiology workflows in the hospitals. With the Osimis AI Collaboration platform, we enable a smoother adoption of the growing number of medical imaging AI solutions available on the market, supporting the radiologists handling an ever growing workload and providing new means for intensive collaboration across multiple hospital departments.“ says Peter Morel. Peter has more than 30 years of professional experience in software solutions sales and alliance building, in international and growth environments: Siemens Atea, Compaq, Amdocs. He is a co-founder of Xenit Solutions, a Smart Content Management solutions provider and integrator, servicing customers in Europe, USA and Asia/Australia. He holds a Vlerick MBA and a Master Degree Civil Engineering in software from the University of Ghent.
Cedric Constant leaves the company to join a venture capital fund as an entrepreneur-in-residence to build and scale a new health tech start-up. He says: “I am proud of what we have achieved with the team, repositioning the company on the very promising imaging AI market, and offering radiologists the imaging AI operating system (OS) of the future. The traction we’ve got so far, with a fast-growing number of customers and prospects clearly demonstrates the potential of the model and the quality of the execution by the team. I warmly thank the team and wish them all the best in continuing these developments.”
Osimis welcomes as well Dr. Sergey Morozov, MD, PhD, MPH who shall join very soon as full-time Chief Innovation Officer (CIO). Sergey is a well-known expert in Europe and the U.S., having been president of the European Society of Medical Imaging Informatics (EuSoMII). He served previously as CEO of the Diagnostics and Telemedicine Center in Moscow, leading the biggest EMEA regional RIS deployment, establishing the largest municipal teleradiology center and orchestrating an array of AI services integration into routine clinical workflow of a hundred hospitals. He is relocating to Belgium with his family. He says: ”I am honored to join the Osimis team at the center of Europe in order to further develop imaging informatics at the international level, to leverage radiologists’ practice by integrating augmented intelligence and to transform healthcare practices in the directions of efficiency and highest quality.”
The management team is therefore reinforced besides co-founder Frédéric Lambrecht as Chief Business Development Officer and Prof. Dr. Erik Ranschaert, MD, PhD and AI Radiology Expert, as part-time Chief Medical Officer, and also a past president of EuSoMII.
Osimis was founded in 2015 around the original free and open-source project "Orthanc" led by its designer Prof. Sébastien Jodogne, PhD in Computer Science. Sebastien remains a shareholder and
advisor to the company while being an Assistant Professor at UCLouvain, dedicated to Computer science applied to life sciences.
Ir. Peter Morel is starting in his new role on May 2nd. The transition will be carried out in close cooperation with Cédric Constant.
Peter Morel, CEO: email@example.com
Jacques Galloy, Chairman of the Board
Peter MOREL, CEO
Sergey MOROZOV, soon CIO
From left to right: Fred LAMBRECHTS, co-founder & CBDO, Jacques GALLOY, Chairman of the Board, Peter MOREL, CEO, Sergey MOROZOV, soon CIO
Part of Osimis team with CEO Peter MOREL
Osimis Board of Directors with observers and management. From left to right: Jacques GALLOY, Chairman of the Board, Marleen LIMBOURG (Noshaq), Sergey MOROZOV (CIO), Peter MOREL (CEO), Gauthier PHILIPPART (Trasis), Catherine CEULEMANS, (CFO), Sébastien ASSOUAD (WSL), Géry LEFEVRE (SRIW-WING), Fred LAMBRECHTS (CBDO), Michel LEBRUN (BeAngels).
ABOUT OSIMIS :
Osimis is a pioneer in the field of medical imaging software solutions, associated solutions and related services aimed at enabling interoperability between players in the clinical and medical research fields. Incubated by WSL and located in Liège (Belgium), the company was created following the worldwide success of Orthanc. It now employs 15 people and had sales of around EUR 0.5m in 2021 in 4 countries and 2 continents. Osimis has developed into a medical imaging AI integration platform, offering hospitals a single integration technology for any AI vendors (5 top performers in the current portfolio) and delivering deep and seamless integration that maximizes patients’ outcome and optimizes hospitals’ return on AI investments. https://osimis.io
Downloaded over 350,000 times worldwide since 2011, Orthanc is a free and open-source server for web-enabled medical imaging. For his academic work on Orthanc, Sébastien Jodogne, co-founder of Osimis and currently Assistant Professor at UCLouvain, was the winner of one of the international free software awards given annually by the Free Software Foundation in Boston (USA), following Guido van Rossum (Python, 2001) and Wikipedia (2005). The Orthanc intellectual property is shared between the Centre Hospitalier Universitaire de Liège, Osimis and Université Catholique de Louvain. https://www.orthanc-server.com
Press release in EN available here.
Press release in FR available here.
Press release in NL available here.